cholestyramine resin has been researched along with Coronary Heart Disease in 175 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 113 (64.57) | 18.7374 |
| 1990's | 43 (24.57) | 18.2507 |
| 2000's | 14 (8.00) | 29.6817 |
| 2010's | 4 (2.29) | 24.3611 |
| 2020's | 1 (0.57) | 2.80 |
| Authors | Studies |
|---|---|
| Hernán, MA; Madenci, AL; Murray, EJ; Wanis, KN | 1 |
| Chiba, Y; Taguri, M | 1 |
| Braunwald, E; Coady, S; Domanski, M; Fleg, J; Gosen, C; Kirby, R; Knatterud, G; Sachdev, V; Tian, X | 1 |
| Gupta, A; Guyomard, V; Myint, PK; Rehman, HU; Zaman, MJ | 1 |
| Chiba, Y | 1 |
| Plans-Rubió, P | 2 |
| Nagai, Y; Yamashita, S | 1 |
| BLACKET, RB; BROWN, WD; WOODHILL, J | 1 |
| Clark, LT | 1 |
| Charlotte, N; Sani, M | 1 |
| Brown, BG; Gotto, AM; Kolasa, MW; Krasuski, RA; Maranian, AM; Michalek, JE; Monick, E; Personius, BE; Whitney, EJ | 1 |
| Bang, H; Colindres, RE; Hogan, SL; Kshirsagar, AV; Shoham, DA; Simpson, RJ | 1 |
| Cai, Z; Kuroki, M; Pearl, J; Tian, J | 1 |
| Stamler, J | 2 |
| Aldrich, RF; Battaglini, JW; Brensike, JF; Kelsey, SF; Levy, RI; Loh, IK; Moriarty, DJ; Passamani, ER; Richardson, JM; Stone, NJ | 1 |
| Aldrich, RF; Battaglini, JW; Brensike, JF; Epstein, SE; Kelsey, SF; Levy, RI; Loh, IK; Passamani, ER; Richardson, JM; Stone, NJ | 1 |
| Simons, LA | 1 |
| Podell, RN | 1 |
| Augustin, J | 1 |
| Durrington, PN; Miller, JP | 1 |
| Rifkind, BM | 3 |
| Malinow, MR | 1 |
| Oliver, MF | 1 |
| Himmelstein, DU; Woolhandler, S | 1 |
| Janus, ED; Nye, ER; Scott, PJ | 1 |
| Nash, DT | 1 |
| Nestel, PJ | 1 |
| Glueck, CJ | 1 |
| Farinaro, E; Mancini, M; Montefusco, S; Postiglione, A | 1 |
| Kuo, PT | 2 |
| Johnstone, JR | 2 |
| Katan, MB | 1 |
| Aldrich, RF; Battaglini, JW; Brensike, JF; Detre, KM; Epstein, SE; Fisher, MR; Kelsey, SF; Levy, RI; Loh, IK; Moriarty, DJ; Myrianthopoulos, MB; Passamani, ER; Richardson, JM; Stone, NJ | 1 |
| Miettinen, TA | 3 |
| Schade, RW | 1 |
| Tan, MH | 1 |
| Rogers, MP | 1 |
| Kolb, S; Sailer, D | 1 |
| Schettler, G | 1 |
| Bard, JM; Dallongeville, J; Duriez, P; Fruchart, JC; Hagen, E; Ose, L; Pfister, P | 1 |
| Peters, TK | 1 |
| Ginsberg, HN | 1 |
| Gotto, AM; Yeshurun, D | 1 |
| Barnhart, HX; Sampson, AR | 1 |
| Davis, CE; Kritchevsky, SB; Morris, DL | 1 |
| Evans, D; Halliday, J; Kinlay, S; O'Connell, D | 1 |
| Brunt, JN; Coltart, DJ; Jackson, P; Lewis, B; Lewis, ES; Mandalia, S; Watts, GF | 1 |
| Abolafia, JM; Davis, CE; Jenner, JL; Lamon-Fava, S; Levy, RI; Lippel, K; McNamara, JR; Ordovas, JM; Schaefer, EJ | 1 |
| Rubins, HB | 1 |
| Coates, PM; Cortner, JA; Jarvik, GP; Liacouras, CA | 1 |
| Kritchevsky, SB; Morris, DL | 1 |
| Hunsberger, SA; Proschan, MA | 1 |
| Barter, PJ; Rye, KA | 1 |
| Gibaldi, M; Kradjan, W | 1 |
| Watts, GF | 1 |
| Bambauer, R; Müller, UA; Schiel, R | 1 |
| Corrigan, F | 1 |
| Ito, MK; Shabetai, R | 1 |
| Andrews, TC; Green, G; Kalenian, R; Personius, BE; Whitney, EJ | 1 |
| Barrett-Connor, E | 1 |
| Avorn, J; Bohn, RL; Lacour, A; LeLorier, J; Mogun, H; Monane, M; Monette, J | 1 |
| Auriemo, C; Martinez, TL; Novazzi, JP; Pinto, Ldo E | 1 |
| Gordon, BR; Saal, SD | 1 |
| Oster, G; Thompson, D | 1 |
| Hjalte, K; Lindgren, B; Persson, U | 1 |
| Gonzalez, ER | 1 |
| Fukuzawa, S; Inagaki, M; Inoue, T; Morooka, S; Ozawa, S | 1 |
| Benesch, L; Bestehorn, HP; Betz, P; Blümchen, G; Böcker, JF; Braunagel, K; Claus, J; Kappenberger, L; Kiefer, H; Leimenstoll, B; Mathes, P; Meister, G; Neiss, A; Peters, K; Petersen, J; Rensing, UF; Roskamm, H; Samek, L; Schemeitat, K; Schuon, J; Spinder, M; Stiepel, E; Wieland, H | 1 |
| Agrawal, R; Arntz, HR; Fischer, F; Linderer, T; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W | 1 |
| Denne, JS | 1 |
| Agrawal, R; Arntz, HR; Fischer, F; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W | 1 |
| Nakaya, N | 1 |
| Beckmann, S; Bocksch, W; Gross, M; Hausmann, D; Karsch, KR; Koschyk, DH; Kreuzer, J; Schartl, M; Voelker, W | 1 |
| Bhatnagar, D | 1 |
| Lowenthal, R; Myant, NB; Thompson, GR | 1 |
| Lloyd, JK | 1 |
| Rider, AK | 1 |
| Kanaide, H; Nakamura, M | 1 |
| Allen, DM; Chapell, J; Pearse, RG; Rose, V | 1 |
| Lloyd, JK; West, RJ | 2 |
| Grundy, SM | 3 |
| Scott, HW | 1 |
| Hazzard, WR | 1 |
| Parsons, WB | 1 |
| Tierney, E | 1 |
| Itakura, H | 1 |
| Brunt, JN; Coltart, DJ; Lewis, B; Lewis, ES; Mann, JI; Smith, LD; Swan, AV; Watts, GF | 1 |
| Freedman, LS; Graubard, BI; Schatzkin, A | 1 |
| Bobbio, M; Brusca, A | 1 |
| Angelin, B; Berglund, L; Bondjers, G; Eriksson, M; Fager, G; Olofsson, SO; Wiklund, O | 1 |
| Ascoop, CA; Erkelens, DW; Martens, LL; Rutten, FF | 2 |
| Arai, M; Fukami, M; Fukushige, J; Ito, T; Kuroda, M; Shiomi, M; Tamura, A; Tsujita, Y; Watanabe, Y | 1 |
| Miller, NE | 1 |
| Amarasingham, R | 1 |
| Janus, ED | 1 |
| Rywik, S | 1 |
| Gohlke, H | 1 |
| Weinberger, MH | 1 |
| Brensike, J; Detre, KM; Kelsey, SF; Krauss, RM; Levy, RI; Lindgren, FT; Vranizan, K; Williams, PT | 1 |
| Islami, Y; Ribeiro, LG | 1 |
| Anding, RH; Lueg, MC | 1 |
| Levy, RI | 3 |
| Epstein, AM; Oster, G | 1 |
| Eisenberg, JM; Kinosian, BP | 1 |
| Alig, J; Stacpoole, PW | 1 |
| Tyroler, HA | 1 |
| Naito, HK | 1 |
| Lewis, B | 1 |
| Castelli, WP | 1 |
| Davidoff, F | 1 |
| Gotto, AM; Jones, PH; Scott, LW | 1 |
| Gotto, AM | 2 |
| Davis, CE; Glueck, CJ; Gordon, DJ; Nelson, JJ; Tyroler, HA | 1 |
| Gordon, DJ; Knoke, J; Probstfield, JL; Superko, R; Tyroler, HA | 1 |
| Brewer, HB; Hoeg, JM; Starzl, TE | 1 |
| Mikunis, RI; Serkova, VK | 1 |
| Proniv, LN; Vygovskiĭ, VP | 1 |
| Hjermann, I | 1 |
| Miller, WW | 1 |
| Kronmal, RA | 1 |
| Aldrich, RF; Brensike, JF; Detre, KM; Epstein, SE; Kelsey, SF; Levy, RI; Loh, IK; Passamani, ER; Richardson, JM; Stone, NJ | 1 |
| Grimm, RH; Hunninghake, DB | 1 |
| Adolph, R; Glueck, CJ; Rice, V; Spitz, HB; Stein, EA | 1 |
| Adams, DD | 1 |
| Ducimetière, P | 1 |
| Klimov, AN; Nikulchev, NG | 1 |
| Rufli, T; Stähelin, H | 1 |
| Levy, RI; Rifking, BM | 1 |
| Fallat, RW; Glueck, CJ; Tsang, R | 1 |
| Duck, HJ; Fleischmann, HJ; Neugebauer, A; Schauer, J; Trenckmann, H | 1 |
| Edwards, IR; Frenk, E; Walker, AE | 1 |
| Trowell, H | 1 |
| Krikler, DM | 1 |
| Blumenthal, S; Jesse, MJ | 1 |
| Bellon, EM; DePalma, RG; Insull, W; Robinson, AV; Roth, WT | 1 |
| Jepson, EM | 1 |
| Bavina, MV; Koropova, GI; Lobova, NM; Perova, NV | 1 |
| Connor, WE | 1 |
| Gresham, GA; Howard, AN | 1 |
| Bencze, WL; DeStevens, G; Hess, R | 1 |
| Garcia, MJ; Kannel, WB; McNamara, PM; Pearson, G | 1 |
| Ostrander, LD | 1 |
| Adamson, G; Strisower, B; Strisower, EH | 1 |
| Segal, MM | 1 |
| Barrillon, A; Binet, JP; de Gennes, JL; Hazan, E; Lenègre, J | 1 |
43 review(s) available for cholestyramine resin and Coronary Heart Disease
| Article | Year |
|---|---|
Systematic review on evidence of the effectiveness of cholesterol-lowering drugs.
Topics: Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Coronary Disease; Drug Therapy, Combination; Evidence-Based Practice; Ezetimibe; Fatty Acids, Omega-3; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Patient Selection; Phytosterols; Practice Guidelines as Topic; Primary Prevention; Risk Assessment; Risk Factors; Risk Reduction Behavior; Secondary Prevention; Treatment Outcome | 2010 |
[Treatment of high blood cholesterol in patients with coronary heart disease].
Topics: Anion Exchange Resins; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Primary Prevention; Probucol; Receptors, LDL; Risk Factors | 2003 |
Optimizing lipid lowering in patients at risk.
Topics: Anticholesteremic Agents; Azetidines; Bile Acids and Salts; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Absorption; Risk Assessment | 2004 |
Clinical aspects of hyperlipidaemia.
Topics: Adult; Child; Cholestyramine Resin; Chylomicrons; Coronary Disease; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Lipoproteins; Lipoproteins, HDL; Xanthomatosis | 1984 |
Experimental models of atherosclerosis regression.
Topics: Animals; Arteriosclerosis; Cholesterol, Dietary; Cholestyramine Resin; Coronary Disease; Disease Models, Animal; Haplorhini; Medicago sativa; Rabbits; Saponins; Time Factors | 1983 |
[Hyperlipoproteinemia type II].
Topics: Adolescent; Adult; Cecum; Child; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Coronary Disease; Dextrothyroxine; Diet; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Ileum; Lipoproteins, LDL; Neomycin; Nicotinic Acids; Plasmapheresis; Portacaval Shunt, Surgical; Xanthogranuloma, Juvenile | 1980 |
HDL-cholesterol: the negative risk factor for coronary heart disease.
Topics: Adult; Age Factors; Alcoholism; Child; Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Dietary Fats; Female; Humans; Hyperlipoproteinemias; Infant, Newborn; Lipoproteins, HDL; Male; Nicotinic Acids; Obesity; Physical Exertion; Racial Groups; Risk; Sex Factors; Smoking | 1980 |
Update on the treatment of hypercholesterolemia, with a focus on HMG-CoA reductase inhibitors and combination regimens.
Topics: Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Coronary Disease; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Niacin | 1995 |
Hyperlipidemia: perspectives in diagnosis and treatment.
Topics: Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet, Fat-Restricted; Diet, Reducing; Exercise; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Niacin; Probucol; Risk; Triglycerides | 1995 |
Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.
Topics: Adolescent; Apolipoproteins B; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Energy Intake; Female; Genetic Linkage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Lipoproteins, VLDL; Liver; Male; Multigene Family; Niacin; Phenotype; Polymorphism, Genetic; Triglycerides | 1993 |
High density lipoproteins and coronary heart disease.
Topics: Animals; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein A-II; Arteriosclerosis; Cholesterol, HDL; Cholestyramine Resin; Clinical Trials as Topic; Comorbidity; Coronary Disease; Diabetes Mellitus, Type 2; Gene Expression; Humans; Hyperlipidemias; Lipoproteins, HDL; Mice; Mice, Transgenic; Risk Factors | 1996 |
Treating elevated cholesterol levels: the great Satan in perspective.
Topics: Animals; Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Gemfibrozil; Health Policy; Humans; Hypercholesterolemia; Risk Factors; United States | 1996 |
Lowering cholesterol in patients with coronary heart disease: are we ready yet?
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Humans; Hypolipidemic Agents; Simvastatin | 1997 |
Cost-effectiveness of drug therapy for hypercholesterolaemia: a review of the literature.
Topics: Age Factors; Cholestyramine Resin; Colestipol; Coronary Disease; Cost-Benefit Analysis; Humans; Hypercholesterolemia; Lovastatin; Risk Factors; Sex Factors; Treatment Outcome | 1992 |
The pharmacoeconomic benefits of cholesterol reduction.
Topics: Cholestyramine Resin; Coronary Disease; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Health Care Costs; Hospitalization; Humans; Hypercholesterolemia; Risk Factors; United States | 1998 |
[Anion exchange resin].
Topics: Animals; Anion Exchange Resins; Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Humans; Hyperlipidemias | 2001 |
Should pediatric patients with hyperlipidemia receive drug therapy?
Topics: Anticholesteremic Agents; Child; Cholestyramine Resin; Coronary Disease; Fatty Acids, Omega-3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Niacin; Psyllium; Risk Assessment | 2002 |
Hyperlipidaemia in children.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cholestasis; Cholesterol; Cholestyramine Resin; Chylomicrons; Coronary Disease; Diabetes Complications; Electrophoresis; Fasting; Glycogen Storage Disease; Glycogen Storage Disease Type I; Humans; Hypercholesterolemia; Hyperlipidemias; Hypothyroidism; Infant; Lipoproteins; Liver Diseases; Nephrotic Syndrome; Puberty; Triglycerides; Xanthomatosis | 1975 |
[Current studies on antilipemic agents].
Topics: Animals; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Humans; Hypolipidemic Agents; Lipoproteins, VLDL; Resins, Plant; Triglycerides | 1975 |
Treatment of hypercholesterolemia.
Topics: Animals; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Diet, Reducing; Dietary Fats; Fats, Unsaturated; Humans; Hypercholesterolemia; Ileum; Intestinal Absorption; Nicotinic Acids; Triglycerides | 1977 |
Cholesterol-lowering drugs as cardioprotective agents.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Niacin; Probucol | 1992 |
Pharmacological intervention for altering lipid metabolism.
Topics: Animals; Cholestyramine Resin; Coronary Disease; Gemfibrozil; Humans; Lipid Metabolism; Lipids; Niacin | 1990 |
[Significance of hypercholesterolemia for epidemiology, prevention and pathogenesis of coronary heart diseases].
Topics: Arteriosclerosis; Cholesterol; Cholestyramine Resin; Coronary Disease; Female; Humans; Hypercholesterolemia; Male; Sex Factors | 1989 |
Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines.
Topics: Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Follow-Up Studies; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Male; Probucol; Triglycerides | 1988 |
Changing perspectives in the prevention of coronary artery disease.
Topics: Animals; Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Health Promotion; Humans; Lipids; Long-Term Care; Male; Motivation; Patient Education as Topic; Random Allocation; Risk | 1986 |
Advances in the treatment of coronary heart disease: fish oils, cholestyramine, and mevinolin.
Topics: Animals; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Dietary Fats, Unsaturated; Enterohepatic Circulation; Fatty Acids, Unsaturated; Fish Oils; Humans; Ion Exchange Resins; Lipid Metabolism; Lovastatin; Male; Middle Aged; Naphthalenes | 1987 |
Review of lipid-lowering clinical trials in relation to observational epidemiologic studies.
Topics: Adolescent; Adult; Age Factors; Aged; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Diet; Double-Blind Method; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Random Allocation; Risk | 1987 |
Reducing cardiac deaths with hypolipidemic drugs.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Feeding Behavior; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Niacin; Patient Education as Topic; Pentanoic Acids; Probucol | 1987 |
Guidelines for individual therapy of hyperlipidaemia.
Topics: Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Hyperlipidemias; Lipoproteins; Male | 1987 |
Cholesterol: what it means in 1986.
Topics: Adult; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Lipoproteins; Male; Middle Aged; Prognosis; Risk | 1986 |
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides | 1986 |
Treatment of hyperlipidemia.
Topics: Adult; Arteriosclerosis; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Female; Humans; Hyperlipidemias; Lipoproteins, HDL; Liver; Male; Receptors, LDL; Risk; Smoking | 1986 |
Review of primary prevention trials of coronary heart disease.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Pressure; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dietary Fats; Electrocardiography; Humans; Male; Middle Aged; Physical Exertion; Risk; Smoking Prevention; Stress, Psychological | 1985 |
Lipid lowering drugs and hyperlipidaemia.
Topics: Biological Transport; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Coronary Disease; Humans; Hyperlipidemias; Infant, Newborn; Lipid Metabolism; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Models, Biological; Nicotinic Acids; Phospholipids; Thyroxine; Triglycerides | 1973 |
Hypercholesterolemia and hypertriglyceridemia in children. A pediatric approach to primary atherosclerosis prevention.
Topics: Arteriosclerosis; Cardiovascular Diseases; Child; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Coronary Disease; Economics; Fats; Fatty Acids; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Triglycerides | 1974 |
Therapeutics XIX. Lipid lowering agents.
Topics: Animals; Arteriosclerosis; Blood Protein Disorders; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet Therapy; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipid Metabolism; Lipoproteins; Metabolic Diseases; Nicotinic Acids; Triglycerides; Xanthomatosis | 1972 |
Dietary fibre and coronary heart disease.
Topics: Animals; Bile Acids and Salts; Cellulose; Cholesterol; Cholestyramine Resin; Coronary Disease; Defecation; Diet; Diet, Vegetarian; Diverticulum, Colon; Feces; Feeding Behavior; Food Analysis; Humans; Ion Exchange Resins; Male; Meat; Middle Aged; Plants, Edible | 1972 |
[Drug prevention of coronary disease].
Topics: Anticholesteremic Agents; Antihypertensive Agents; Cholestyramine Resin; Clofibrate; Coronary Disease; Diabetes Mellitus; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Neomycin | 1972 |
Therapy of lipid disorders.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Dextrothyroxine; Diet Therapy; Drug Therapy, Combination; Female; Hospitals, Psychiatric; Humans; Hyperlipidemias; Male; Middle Aged; Neomycin; Nicotinic Acids; Sex Factors | 1973 |
Atherosclerosis: a pediatric problem?
Topics: Adolescent; Adult; Arteriosclerosis; Blood; Child; Cholesterol; Cholestyramine Resin; Coronary Disease; Diabetes Complications; Female; Heterozygote; Humans; Hyperlipidemias; Hypertension; Infant, Newborn; Male; Middle Aged; Obesity; Pediatrics; Smoking; Umbilical Cord | 1972 |
Measures to reduce the serum lipid levels in coronary heart disease.
Topics: Adult; Anticholesteremic Agents; Butyrates; Cholesterol; Cholestyramine Resin; Coronary Disease; Dextrothyroxine; Diet Therapy; Dietary Fats; Estrogens; Humans; Hypercholesterolemia; Lipids; Middle Aged; Neomycin; Nicotinic Acids; Sterols | 1968 |
Dietary aspects of atheroslcerosis and thrombosis.
Topics: Animals; Arachis; Arteriosclerosis; Butter; Cholesterol; Cholestyramine Resin; Coronary Disease; Depression, Chemical; Diet; Diet, Atherogenic; Dietary Fats; Fatty Acids, Essential; Glycine max; Haplorhini; Humans; Hypercholesterolemia; Lipids; Medicago sativa; Rabbits; Rats; Thrombosis; Triglycerides; Zea mays | 1968 |
Hypolipidemic agents.
Topics: Acetates; Adult; Animals; Azoles; Butyrates; Cholesterol; Cholestyramine Resin; Coronary Disease; Diet; Dogs; Esters; Estrogens; Female; Haplorhini; Heart Diseases; Humans; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Mevalonic Acid; Mice; Middle Aged; Nicotinic Acids; Oxazoles; Prostaglandins; Pyrazoles; Pyridines; Rats; Steroids; Thyroxine | 1969 |
52 trial(s) available for cholestyramine resin and Coronary Heart Disease
| Article | Year |
|---|---|
Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Postoperative Care; Prospective Studies; Treatment Outcome | 2008 |
A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events.
Topics: Aged; Cholesterol, HDL; Cholestyramine Resin; Coronary Angiography; Coronary Disease; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Exercise Therapy; Female; Gemfibrozil; Humans; Hypolipidemic Agents; Life Style; Male; Middle Aged; Niacin | 2005 |
The effect of cholesterol reduction with cholestyramine on renal function.
Topics: Adult; Anticholesteremic Agents; Cholesterol, Dietary; Cholestyramine Resin; Combined Modality Therapy; Coronary Disease; Diet, Fat-Restricted; Double-Blind Method; Glomerular Filtration Rate; Humans; Hyperlipoproteinemia Type II; Kidney; Male; Middle Aged; Risk Factors; Treatment Failure | 2005 |
The lipid research clinics trial.
Topics: Adult; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Random Allocation | 1984 |
Cholesterol lowering and the risk of coronary heart disease.
Topics: Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Colonic Neoplasms; Coronary Disease; Female; Humans; Male; Random Allocation | 1984 |
Pharmacological trials: primary and secondary prevention of coronary heart disease.
Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone | 1983 |
Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.
Topics: Adult; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Middle Aged | 1984 |
The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Triglycerides | 1984 |
The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.
Topics: Adult; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Lipoproteins; Male; Middle Aged; Mortality | 1984 |
The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Male | 1984 |
The lipid hypothesis is proven.
Topics: Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Humans; Lipoproteins, LDL; Male; Middle Aged; Risk | 1984 |
Coronary disease prevention. Proof of the anticholesterol pudding.
Topics: Adult; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Gastrointestinal Diseases; Humans; Male | 1984 |
[Primary prevention of coronary disease by modification of the lipids].
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Dietary Fats; Double-Blind Method; Humans; Hyperlipoproteinemias; Lipid Metabolism; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Placebos; Risk | 1984 |
Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
Topics: Adult; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Middle Aged; Random Allocation | 1984 |
Lipid Research Clinics Program.
Topics: Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Female; Humans; Hypercholesterolemia; Male; Middle Aged | 1984 |
Hypercholesterolaemia and coronary heart disease: an answer.
Topics: Adult; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Middle Aged | 1984 |
Free care, cholestyramine, and health policy.
Topics: Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis; Fees, Medical; Health Policy; Humans; Insurance, Health; Male; Middle Aged; Preventive Health Services; United States | 1984 |
National Heart, Lung, and Blood Institute type II Coronary Intervention Study: design, methods, and baseline characteristics.
Topics: Adult; Angiography; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Female; Follow-Up Studies; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Male; Middle Aged; National Institutes of Health (U.S.); Random Allocation; Research Design; United States | 1982 |
Pre-entry characteristics of participants in the Lipid Research Clinics' Coronary Primary Prevention Trial.
Topics: Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Hyperlipoproteinemia Type II; Lipids; Random Allocation | 1983 |
Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.
Topics: Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein C-III; Apolipoproteins B; Apolipoproteins C; Apolipoproteins E; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Male; Middle Aged; Risk Factors; Triglycerides | 1995 |
Fluvastatin in severe hypercholesterolemia: analysis of a clinical trial database.
Topics: Aged; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipoproteinemia Type II; Indoles; Information Systems; Longitudinal Studies; Male; Middle Aged; Placebos; Risk Factors; Triglycerides | 1995 |
Serum carotenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study.
Topics: Adult; Carotenoids; Cholestyramine Resin; Cohort Studies; Coronary Disease; Follow-Up Studies; Humans; Hyperlipidemias; Incidence; Male; Middle Aged; Placebos; Risk | 1994 |
Nutrient intake and progression of coronary artery disease.
Topics: Basal Metabolism; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Dietary Fats; Dietary Fiber; Energy Intake; Fatty Acids; Fatty Acids, Monounsaturated; Humans; Male; Middle Aged; Nutrition Assessment; Nutritional Physiological Phenomena | 1994 |
Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.
Topics: Adult; Aged; Case-Control Studies; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Lipids; Lipoprotein(a); Logistic Models; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Risk Factors | 1994 |
Changes in dietary fat intake preceding the diagnosis of cancer.
Topics: Adult; Bias; Cholestyramine Resin; Coronary Disease; Dietary Fats; Energy Intake; Follow-Up Studies; Humans; Hyperlipoproteinemia Type II; Male; Mental Recall; Middle Aged; Neoplasms; Tennessee | 1995 |
Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group.
Topics: Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins B; Cholesterol, LDL; Cholestyramine Resin; Coronary Angiography; Coronary Disease; Dietary Fats; Genotype; Humans; Male; Middle Aged; Nutritional Status; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Promoter Regions, Genetic; Treatment Outcome | 1995 |
Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis.
Topics: Adolescent; Adult; Anticholesteremic Agents; Blood Component Removal; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Longitudinal Studies; Lovastatin; Male; Middle Aged; Niacin; Pravastatin; Quality of Life | 1995 |
Pravastatin alone and in combination with low-dose cholestyramine in patients with primary hypercholesterolemia and coronary artery disease.
Topics: Adult; Aged; Anticholesteremic Agents; Cholestyramine Resin; Coronary Disease; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Triglycerides | 1997 |
Effect of gemfibrozil +/- niacin +/- cholestyramine on endothelial function in patients with serum low-density lipoprotein cholesterol levels <160 mg/dl and high-density lipoprotein cholesterol levels <40 mg/dl.
Topics: Aged; Brachial Artery; Cholestyramine Resin; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Male; Middle Aged; Niacin; Reference Values; Vasodilation | 1997 |
[Lipid intervention and coronary heart disease in men less than 56 years of age. The Coronary Intervention Study: CIS].
Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Diet, Fat-Restricted; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Simvastatin | 1999 |
[Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study].
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Niacin; Pravastatin; Prospective Studies; Treatment Outcome | 1999 |
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Chemoprevention; Chi-Square Distribution; Cholesterol, LDL; Cholestyramine Resin; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Drug Combinations; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Niacin; Odds Ratio; Peripheral Vascular Diseases; Pravastatin; Regression Analysis; Statistics, Nonparametric; Stroke; Survival Rate; Treatment Outcome | 2000 |
Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease.
Topics: Anticholesteremic Agents; Arteriosclerosis; Arthralgia; Atorvastatin; Butyrates; Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Coronary Disease; Creatinine; Exanthema; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Patient Dropouts; Pyrroles; Treatment Outcome; Triglycerides; Ultrasonography, Interventional; Venous Thrombosis | 2001 |
The coronary primary prevention trial: design and implementation: the Lipid Research Clinics Program.
Topics: Adult; Canada; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Humans; Hyperlipoproteinemias; Male; Middle Aged; United States | 1979 |
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
Topics: Angina Pectoris; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Combined Modality Therapy; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Humans; Male; Middle Aged; Remission Induction; Treatment Outcome | 1992 |
Cholesterol-lowering drugs as cardioprotective agents.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Niacin; Probucol | 1992 |
The Lipid Research Clinics Coronary Primary Prevention Trial. Results of 6 years of post-trial follow-up. The Lipid Research Clinics Investigators.
Topics: Cause of Death; Cholelithiasis; Cholestyramine Resin; Cohort Studies; Coronary Disease; Double-Blind Method; Follow-Up Studies; Humans; Hypercholesterolemia; Incidence; Male; Neoplasms; Primary Prevention; Survival Analysis | 1992 |
[Is hypolipemic treatment effective as a preventive measure?].
Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Europe; Humans; Hypercholesterolemia; Hyperlipoproteinemias; International Cooperation; Male; Middle Aged | 1989 |
Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men.
Topics: Adult; Cholestyramine Resin; Coronary Angiography; Coronary Disease; Diet; Humans; Hypercholesterolemia; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Probability; Regression Analysis | 1987 |
Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines.
Topics: Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Follow-Up Studies; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Male; Probucol; Triglycerides | 1988 |
Changing perspectives in the prevention of coronary artery disease.
Topics: Animals; Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Health Promotion; Humans; Lipids; Long-Term Care; Male; Motivation; Patient Education as Topic; Random Allocation; Risk | 1986 |
Advances in the treatment of coronary heart disease: fish oils, cholestyramine, and mevinolin.
Topics: Animals; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Dietary Fats, Unsaturated; Enterohepatic Circulation; Fatty Acids, Unsaturated; Fish Oils; Humans; Ion Exchange Resins; Lipid Metabolism; Lovastatin; Male; Middle Aged; Naphthalenes | 1987 |
Review of lipid-lowering clinical trials in relation to observational epidemiologic studies.
Topics: Adolescent; Adult; Age Factors; Aged; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Diet; Double-Blind Method; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Random Allocation; Risk | 1987 |
Report on the Lipid Research Clinic trials.
Topics: Adult; Cholesterol, Dietary; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Male; Middle Aged; Random Allocation | 1987 |
Cholesterol: what it means in 1986.
Topics: Adult; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Lipoproteins; Male; Middle Aged; Prognosis; Risk | 1986 |
Dietary and other correlates of changes in total and low density lipoprotein cholesterol in hypercholesterolemic men: the lipid research clinics coronary primary prevention trial.
Topics: Adult; Antihypertensive Agents; Blood Glucose; Body Weight; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Dietary Fats; Fats, Unsaturated; Humans; Hypercholesterolemia; Male; Middle Aged; Random Allocation; Smoking | 1986 |
High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.
Topics: Adult; Cholesterol, HDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Prognosis; Random Allocation; Risk | 1986 |
The Lipid Research Clinics Coronary Primary Prevention Trial.
Topics: Adult; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Death, Sudden; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction | 1986 |
Commentary on the published results of the Lipid Research Clinics Coronary Primary Prevention Trial.
Topics: Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Combined Modality Therapy; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Random Allocation; Research Design; Statistics as Topic | 1985 |
Secondary prevention and lipid lowering: results and implications.
Topics: Angiocardiography; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Diet; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Male; National Institutes of Health (U.S.); Random Allocation; United States | 1985 |
Review of primary prevention trials of coronary heart disease.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Pressure; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dietary Fats; Electrocardiography; Humans; Male; Middle Aged; Physical Exertion; Risk; Smoking Prevention; Stress, Psychological | 1985 |
The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
Topics: Adult; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Digestive System; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Random Allocation; Risk | 1985 |
87 other study(ies) available for cholestyramine resin and Coronary Heart Disease
| Article | Year |
|---|---|
Adjusting for adherence in randomized trials when adherence is measured as a continuous variable: An application to the Lipid Research Clinics Coronary Primary Prevention Trial.
Topics: Adult; Anticholesteremic Agents; Bias; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Incidence; Intention to Treat Analysis; Lipids; Logistic Models; Male; Medication Adherence; Middle Aged; Primary Prevention; Randomized Controlled Trials as Topic | 2020 |
Alternative monotonicity assumptions for improving bounds on natural direct effects.
Topics: Biometry; Causality; Cholestyramine Resin; Coronary Disease; Humans; Hyperlipidemias; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Bounds on controlled direct effects under monotonic assumptions about mediators and confounders.
Topics: Algorithms; Biometry; Cholestyramine Resin; Confounding Factors, Epidemiologic; Coronary Disease; Humans; Male; Middle Aged; Models, Statistical; Myocardial Infarction; Placebos; Prognosis; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 2010 |
The cost effectiveness of statin therapies in Spain in 2010, after the introduction of generics and reference prices.
Topics: Azetidines; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Cost-Benefit Analysis; Drug Therapy, Combination; Drugs, Generic; Ezetimibe; Health Care Costs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Spain; Time Factors | 2010 |
THE EFFECT OF CHOLESTYRAMINE ("MK 135") ON THE SERUM CHOLESTEROL LEVEL IN MAN.
Topics: Angina Pectoris; Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Leg; Male; Myocardial Infarction; Pharmacology; Statistics as Topic; Thyroxine; Toxicology; Vascular Diseases; Xanthomatosis | 1964 |
Lipid-lowering drugs.
Topics: Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Coronary Disease; Ezetimibe; Fatty Acids, Omega-3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Risk Factors; Treatment Outcome | 2004 |
Summaries for patients. Targeting cholesterol treatment toward increasing high-density lipoprotein levels.
Topics: Aged; Cholesterol, HDL; Cholestyramine Resin; Coronary Angiography; Coronary Disease; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Exercise Therapy; Female; Gemfibrozil; Humans; Hypolipidemic Agents; Life Style; Male; Middle Aged; Niacin | 2005 |
Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lovastatin; Meta-Analysis as Topic; Pravastatin; Pyrroles; Risk Factors; Simvastatin; Spain | 2006 |
Bounds on direct effects in the presence of confounded intermediate variables.
Topics: Anticholesteremic Agents; Biometry; Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Male; Programming, Linear; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
The decrease in coronary heart disease mortality. Status and perspectives on the role of cholesterol.
Topics: Adrenergic beta-Antagonists; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Triglycerides | 1984 |
Management of hypercholesterolaemia and cholestyramine.
Topics: Age Factors; Aged; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Middle Aged | 1984 |
Hyperlipidemia: reducing the chances of cardiovascular disease.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Pentanoic Acids; Probucol; Triglycerides | 1984 |
Time to treat cholesterol seriously.
Topics: Adult; Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Male; Middle Aged | 1984 |
Therapy of familial and acquired hyperlipoproteinemia in children and adolescents.
Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Infant; Infant Food; Lipoproteins, LDL; Male; Patient Compliance; Triglycerides | 1983 |
Diet, drugs, and plasma exchange in the treatment of hyperlipidemia in childhood.
Topics: Adolescent; Child; Child, Preschool; Cholesterol, Dietary; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Plasma Exchange; Polyamines | 1983 |
Treating hyperlipidemia to provide salutary effect on coronary artery disease.
Topics: Arteriosclerosis; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Enzyme Inhibitors; Fatty Acids, Unsaturated; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Lipoproteins, LDL | 1984 |
LRC-CPP trial.
Topics: Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia | 1984 |
[Definition and treatment of hypercholesterolemia; consequences of the Lipid Research Clinics study].
Topics: Adult; Cholestyramine Resin; Coronary Disease; Diet; Health Education; Humans; Hypercholesterolemia; Male; Middle Aged | 1984 |
Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis.
Topics: Absorption; Adult; Arteriosclerosis; Bile; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Coronary Disease; Feces; Humans; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism; Lipoproteins; Male; Phytosterols; Squalene; Xanthomatosis | 1980 |
Plasma lipoprotein metabolism in relation to ischaemic heart disease.
Topics: Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Hyperlipoproteinemias; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Triglycerides | 1982 |
[Treatment of coronary heart disease with diet and lipid-reducing agents].
Topics: Adolescent; Adult; Child; Cholestyramine Resin; Clofibrate; Clofibric Acid; Colestipol; Coronary Disease; Dextrothyroxine; Humans; Hypolipidemic Agents; Nicotinic Acids; Risk | 1982 |
Hyperlipidaemia advances and retreats.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Humans; Hyperlipidemias; Lipoproteins, HDL; Male | 1980 |
[Undesirable effects of hypolipemic drugs].
Topics: Adult; Arrhythmias, Cardiac; Avitaminosis; Biliary Tract Diseases; Cholestyramine Resin; Clofibrate; Coronary Disease; Dextrothyroxine; Gastrointestinal Diseases; Gout; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Nicotinic Acids; Phospholipids; Pyridinolcarbamate; Sleep Initiation and Maintenance Disorders | 1980 |
Multiple population models for multivariate random length data--with applications in clinical trials.
Topics: Biometry; Cholestyramine Resin; Controlled Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Humans; Hyperlipoproteinemias; Models, Statistical; Probability; Randomized Controlled Trials as Topic | 1995 |
The cost-effectiveness of different blood-cholesterol-lowering strategies in the prevention of coronary heart disease.
Topics: Adult; Cholesterol; Cholestyramine Resin; Coronary Disease; Cost-Benefit Analysis; Humans; Male; Middle Aged; New South Wales | 1994 |
From clinical trials to clinical practice: generalizing from participant to patient.
Topics: Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Data Interpretation, Statistical; Diffusion of Innovation; Humans; Male; Middle Aged; Physician's Role; Risk Factors | 1994 |
Designed extension of studies based on conditional power.
Topics: Biometry; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Humans; Models, Statistical | 1995 |
Lipid-lowering drugs and mortality.
Topics: Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Hypolipidemic Agents; Pravastatin; Treatment Outcome | 1997 |
Persistence of use of lipid-lowering medications: a cross-national study.
Topics: Aged; Aged, 80 and over; Canada; Cholestyramine Resin; Cohort Studies; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus; Female; Health Care Surveys; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypolipidemic Agents; Male; Multivariate Analysis; Patient Compliance; Socioeconomic Factors; Treatment Refusal; United States | 1998 |
[Combined therapy with cholestyramine and HMG-CoA reductase inhibitors in secondary prevention of coronary disease].
Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Drug Combinations; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged | 1998 |
Choice of lipid-lowering drugs.
Topics: Animals; Cholestyramine Resin; Coronary Disease; Estrogen Replacement Therapy; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoproteins; Niacin | 1998 |
Immunoadsorption and dextran sulfate cellulose LDL-apheresis for severe hypercholesterolemia: the Rogosin Institute experience 1982-1992.
Topics: Adult; Aged; Blood Component Removal; Child; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Dextran Sulfate; Humans; Hypercholesterolemia; Immunosorbent Techniques; Lovastatin; Middle Aged; Niacin; Pilot Projects | 1993 |
Cost-effectiveness of simvastatin versus cholestyramine: results for Sweden.
Topics: Adult; Cholestyramine Resin; Coronary Disease; Cost Savings; Cost-Benefit Analysis; Health Care Costs; Humans; Hypercholesterolemia; Life Expectancy; Lovastatin; Male; Middle Aged; Multivariate Analysis; Sweden | 1992 |
Secondary prevention with lipid lowering therapy in familial hypercholesterolemia: a correlation between new evolution of stenotic lesion and achieved cholesterol levels after revascularization procedures.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Cholestyramine Resin; Coronary Artery Bypass; Coronary Artery Disease; Coronary Disease; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipids; Male; Middle Aged; Probucol | 1999 |
Estimation following extension of a study on the basis of conditional power.
Topics: Algorithms; Anticholesteremic Agents; Bias; Cholestyramine Resin; Coronary Disease; Data Interpretation, Statistical; Research Design; Sample Size | 2000 |
Plasma exchange in the management of homozygous familial hypercholesterolaemia.
Topics: Adult; Aortic Diseases; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Female; Homozygote; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Nicotinic Acids; Plasmapheresis | 1975 |
Should hyperlipoproteinemia be treated in patients with coronary artery disease?
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Body Weight; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet Therapy; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Nicotinic Acids; Resins, Plant; Triglycerides | 1975 |
Primary hyperlipoproteinemia in childhood and adolescence: identification and treatment of persons at risk for premature atherosclerosis.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Coronary Disease; Feeding Behavior; Female; Heart Defects, Congenital; Humans; Hyperlipidemias; Infant; Lipoproteins, LDL; Male; Pedigree; Probability; Risk | 1976 |
Hyperlipidaemia, smoking and hypertension. The place of the hyperlipidaemias.
Topics: Adolescent; Child; Child, Preschool; Cholestyramine Resin; Coronary Disease; Dietary Fats; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Risk; Triglycerides | 1978 |
Ileal bypass in the control of hyperlipidemia and atherosclerosis.
Topics: Adult; Animals; Aorta; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Coronary Disease; Coronary Vessels; Diet, Atherogenic; Dietary Fats; Dogs; Enterohepatic Circulation; Haplorhini; Humans; Hyperlipidemias; Hypothyroidism; Ileum; Iodine Radioisotopes; Jugular Veins; Macaca mulatta; Middle Aged; Transplantation, Autologous | 1978 |
A pathophysiologic approach to managing hyperlipemia.
Topics: Adult; Cholestyramine Resin; Clofibrate; Coronary Disease; Female; Humans; Hyperlipidemias; Lipid Metabolism; Lipoprotein Lipase; Liver; Male; Middle Aged; Nicotinic Acids; Sitosterols; Thyroxine; Triglycerides | 1976 |
Hyperlipidemia: to treat or not to treat.
Topics: Cerebrovascular Disorders; Cholestyramine Resin; Clofibrate; Coronary Disease; Female; Humans; Hyperlipidemias; Hypertension; Male; Nicotinic Acids; Risk; Smoking; Thyroxine | 1975 |
The investigation and treatment of hyperlipidaemia in general practice.
Topics: Adult; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet, Reducing; Family Practice; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Male; Middle Aged | 1975 |
[Treatment of hyperlipidemia].
Topics: Blood Component Removal; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Dietary Fiber; Energy Intake; Female; Humans; Hyperlipidemias; Male; Niceritrol; Pravastatin; Probucol | 1992 |
Statistical validation of intermediate endpoints for chronic diseases.
Topics: Biomarkers; Cholestyramine Resin; Chronic Disease; Coronary Disease; Humans; Hypercholesterolemia; Incidence; Male; Middle Aged; Models, Statistical; Probability; Prospective Studies; Risk Factors | 1992 |
Primary prevention of coronary heart disease with drug therapy. Safety and total mortality issues.
Topics: Adult; Cholestyramine Resin; Coronary Disease; Follow-Up Studies; Humans; Hypercholesterolemia; Male; Primary Prevention; Survival Rate | 1992 |
[The cholesterol question. Disinformed information].
Topics: Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Gemfibrozil; Humans; Hypercholesterolemia; Pilot Projects; Risk Factors | 1991 |
Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins A; Cholestyramine Resin; Coronary Disease; Female; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Naphthalenes; Pravastatin; Receptors, LDL | 1990 |
Clinical benefits and cost-effectiveness of lowering serum cholesterol levels: the case of simvastatin and cholestyramine in The Netherlands.
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Coronary Disease; Cost-Benefit Analysis; Female; Humans; Life Expectancy; Lovastatin; Male; Middle Aged; Netherlands; Risk Factors; Simvastatin | 1990 |
Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramine.
Topics: Animals; Anticholesteremic Agents; Aorta; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Coronary Disease; Heptanoic Acids; Naphthalenes; Phospholipids; Pravastatin; Rabbits; Triglycerides; Xanthomatosis | 1990 |
Cholesterol lowering drugs.
Topics: Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Hypolipidemic Agents | 1990 |
Cost effectiveness of cholesterol-lowering therapy in The Netherlands. Simvastatin versus cholestyramine.
Topics: Adult; Anticholesteremic Agents; Cholestyramine Resin; Coronary Disease; Cost-Benefit Analysis; Female; Humans; Lovastatin; Male; Middle Aged; Netherlands; Simvastatin | 1989 |
Treatment of hyperlipidaemias. Current avenues and new horizons.
Topics: Cholestyramine Resin; Coronary Disease; Gemfibrozil; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipidemias; Hypolipidemic Agents | 1989 |
Antihypertensive therapy and lipids. Paradoxical influences on cardiovascular disease risk.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Cholestyramine Resin; Coronary Disease; Death, Sudden; Diuretics; Humans; Hypertension; Lipid Metabolism; Risk; Sympatholytics | 1986 |
Hypercholesterolemia: new values, new strategies.
Topics: Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Colestipol; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Niacin | 1986 |
Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramine.
Topics: Adult; Aged; Cholestyramine Resin; Coronary Disease; Cost-Benefit Analysis; Humans; Hypercholesterolemia; Life Expectancy; Male; Middle Aged | 1987 |
Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia.
Topics: Cholestyramine Resin; Colestipol; Coronary Disease; Cost-Benefit Analysis; Edible Grain; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Office Visits; Polyamines; Smoking | 1988 |
Cardiovascular disease in women.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Contraceptives, Oral; Coronary Disease; Diet; Female; Gynecology; Humans; Male; Middle Aged; Obstetrics; Physician's Role; Risk Factors; Sex Factors; Triglycerides | 1988 |
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.
Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Male; Middle Aged; Niacin; Patient Compliance; Pentanoic Acids; Probucol; Risk Factors | 1988 |
Liver transplantation for treatment of cardiovascular disease: comparison with medication and plasma exchange in homozygous familial hypercholesterolemia.
Topics: Child; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Homozygote; Humans; Hyperlipoproteinemia Type II; Liver Transplantation; Lovastatin; Male; Naphthalenes; Niacin; Plasma Exchange; Skin Diseases; Xanthomatosis | 1987 |
[Effect of cholestyramine on the clinico-biochemical indices of ischemic heart disease patients].
Topics: Aged; Cholestyramine Resin; Coronary Disease; Drug Evaluation; Energy Metabolism; Humans; Hydroxyproline; Hyperlipoproteinemias; Lipids; Male; Middle Aged | 1987 |
[Use of cholestyramine by patients with chronic ischemic heart disease].
Topics: Adult; Cholestyramine Resin; Coronary Disease; Female; Humans; Hyperlipoproteinemia Type II; Kallikreins; Kinins; Male; Middle Aged | 1987 |
Multiple risk factor intervention in coronary heart disease.
Topics: Adult; Anticholesteremic Agents; Behavior Therapy; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Coronary Disease; Death, Sudden; Finland; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Norway; Risk; Smoking Prevention; World Health Organization | 1985 |
Preventive cardiology for coronary artery disease.
Topics: Cholestyramine Resin; Combined Modality Therapy; Coronary Disease; Humans; Hyperlipidemias; Hypertension; Lipids; Myocardial Infarction; Obesity; Physical Exertion; Risk; Smoking Prevention; Uric Acid | 1985 |
Time to treat cholesterol seriously.
Topics: Cholesterol; Cholestyramine Resin; Coronary Disease; Humans | 1985 |
Cholesterol and coronary artery disease. What do clinicians do now?
Topics: Adolescent; Adult; Aged; Child; Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Risk | 1986 |
Interactions of the major risk factors for coronary heart disease.
Topics: Age Factors; Animals; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Diet, Reducing; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Hypertension; Male; Physical Exertion; Risk; Smoking; Sodium Chloride | 1986 |
Lipids and hypertension. Implications of new guidelines for cholesterol management in the treatment of hypertension.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Coronary Disease; Diet Therapy; Diuretics; Female; Humans; Hypertension; Lipid Metabolism; Lipids; Lipoproteins; Male; Prazosin; Risk; Smoking | 1986 |
Nonprogression of coronary artery atherosclerosis in homozygous familial hypercholesterolemia after 31 months of repetitive plasma exchange.
Topics: Achilles Tendon; Adult; Angiography; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Echocardiography; Female; Homozygote; Humans; Hyperlipoproteinemia Type II; Plasma Exchange; Probucol; Xanthomatosis | 1986 |
Diet and coronary heart disease.
Topics: Adult; Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Male; Middle Aged; Myocardial Infarction | 1985 |
Lowering cholesterol and the incidence of coronary heart disease.
Topics: Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Male; Statistics as Topic | 1985 |
[Hyperlipidemia and coronary disease].
Topics: Adult; Cholestyramine Resin; Coronary Disease; Europe; Humans; Hypercholesterolemia; Hyperlipidemias; Japan; Male; Middle Aged; Risk; United States | 1985 |
[Various pharmacological approaches to normalization of lipid metabolism in patients with arteriosclerosis].
Topics: Adolescent; Adult; Arteriosclerosis; Cholestyramine Resin; Coronary Disease; Humans; Hyperlipidemias; Lipid Metabolism; Lipotropic Agents; Middle Aged | 1973 |
[Xanthomatosis as a symptom of hyperlipidemic metabolic disorders. Relationship of the morphological picture to the lipid of three patients].
Topics: Adult; Arterial Occlusive Diseases; Blood Protein Electrophoresis; Cholestyramine Resin; Chylomicrons; Clofibrate; Coronary Disease; Diet, Reducing; Female; Glucose Tolerance Test; Humans; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Male; Middle Aged; Nicotinic Acids; Xanthomatosis | 1972 |
Hyperlipidemia and coronary artery disease. Prinicples of diet and drug treatment.
Topics: Amino Alcohols; Arteriosclerosis; Carbohydrates; Cholestyramine Resin; Coronary Disease; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Polymers; Triglycerides | 1974 |
[Diagnosis and treatment of risk factors in chronic ischemic heart disease].
Topics: Adult; Age Factors; Arteriosclerosis; Cholestyramine Resin; Chronic Disease; Clofibrate; Coronary Disease; Diabetes Complications; Female; Health Education; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Nicotinic Acids; Obesity; Sex Factors; Smoking | 1974 |
Animal models for the study of progression and regression of atherosclerosis.
Topics: Animals; Aorta; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Coronary Disease; Diet, Atherogenic; Disease Models, Animal; Dogs; Feces; Haplorhini; Hyperlipidemias; Lipoproteins; Macaca; Male; Mesenteric Arteries; Steroids; Thyroid Gland; Thyroxine; Time Factors; Triglycerides | 1972 |
Do fats matter.
Topics: Arteries; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Coronary Disease; Dietary Carbohydrates; Dietary Fats; Electrophoresis; Fats, Unsaturated; Hyperlipidemias; Lipid Metabolism; Phospholipids; Triglycerides; Ultracentrifugation; Xanthomatosis | 1972 |
Use of cholestyramine in treatment of children with familial hypercholesterolaemia.
Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Coronary Disease; Dietary Fats; Feces; Female; Folic Acid; Humans; Hyperlipidemias; Infant; Intestinal Absorption; Lipids; Male; Taste | 1973 |
[The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].
Topics: Adult; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Electrophoresis, Polyacrylamide Gel; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipid Mobilization; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Phospholipids; Sitosterols; Triglycerides | 1973 |
Serum lipid precursors of coronary heart disease.
Topics: Adult; Aged; Arteriosclerosis; Blood Protein Disorders; Body Weight; Cholesterol; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Coronary Disease; Diet Therapy; Epidemiologic Methods; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Male; Middle Aged; Nicotinic Acids; Phospholipids; Prognosis; Sex Factors; Thyroxine; Triglycerides | 1971 |
Cholesterol metabolism in patients with coronary heart disease.
Topics: Adult; Bile Acids and Salts; Body Weight; Carbon Isotopes; Cholesterol; Cholestyramine Resin; Coronary Disease; Electrocardiography; Feces; Female; Glucose Tolerance Test; Glycerides; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Male; Middle Aged; Sterols; Triglycerides; Tritium | 1971 |
Control of biochemical precursors of coronary heart disease.
Topics: Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Coronary Disease; Dextrothyroxine; Diabetes Mellitus; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids; Triglycerides | 1969 |
Treatment of hyperlipidemic states.
Topics: Adult; Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Coronary Disease; Dextrothyroxine; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Nicotinic Acids; Thyroid Hormones; Thyroxine; Triglycerides | 1970 |
Management of excess serum lipid.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Humans; Hyperlipidemias; Ileum; Neomycin; Triglycerides | 1971 |
Treatment of familial hypercholesterolaemia in childhood.
Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Coronary Disease; Diet Therapy; Humans; Hyperlipidemias; Infant; Infant, Newborn | 1968 |
[Basic treatment of coronary atherosclerosis].
Topics: Activities of Daily Living; Angina Pectoris; Anticoagulants; Cholesterol; Cholestyramine Resin; Coronary Angiography; Coronary Disease; Diet, Atherogenic; Diet, Diabetic; Diet, Reducing; Dietary Carbohydrates; Dietary Fats; Fats, Unsaturated; Female; Glucose Tolerance Test; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Lipids; Male; Nicotinic Acids; Smoking; Triglycerides; Uric Acid | 1969 |